Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Class notes

College aantekeningen Cancer Mechanisms and Immune defense (MED-B3MIN04)

Rating
-
Sold
-
Pages
19
Uploaded on
07-04-2025
Written in
2023/2024

Samenvatting van de lectures van minor 04 Cancer Mechanisms and Immune Defense

Institution
Course

Content preview

Summary LE 1 MIN04
Hallmarks of cancer
- Resisting cell death
- Inducing angiogenesis
- Enabling replicative immortality
- Activating invasion metastasis
- Evading growth suppressors
- Sustaining proliferative signaling
- Reprogramming energy metabolism
- Immune evasion, inhibit B and T cells

Melanoma = most aggressive skin cancer
- A asymmetry
- B border
- C color
- D diameter

Chemotherapy = rapid damage to dividing cells

Targeted therapy = target specific pathway
- Mutation is BRAF, without signal from outside it will grow
o BRAFi, MEKi (BRAF works in non epithelial cells)
- Side effects:
o Inhibition signaling proteins in other cells
o Hyperkeratosis

Immunotherapy = stimulation of the immune system
- Non-antigen specific:
o Non-specific stimulation → IFN, IL-2
o Immune checkpoint inhibition (ICI)
▪ Anti-CTLA-4 → CTLA4 (on T-cell) binds 2nd signal (with APC) so T-cell downregulation
▪ Anti-PD1 → PD1 (on T-cell) binds PD-L1 (on tumor cell) producing inhibitory signal
o T-VEC → invades and replicates in tumour cells selectively, lyse tumour cells
- Antigen-specific therapy:
o Dendritic cell vaccination
o Adoptive T cell transfer

Primary cell cultures → directly isolated from an organism
- Lifespan = limited
- Retain characteristics of normal cells/tissue
Cell line culture → permanently established cell culture (immortalized)
- Lifespan = unlimited
- Derived from primary cell culture
- Mel624, human melanoma cell line, epithelial-like cells, adherent

Subculture → cell passaging
- Because of: exhaustion medium, cell density too high, increasing cell numbers

,Suspension cells → free-floating single cells or clumps of a few cells
Adherent cells → single layer of cells (monolayer)
Unhealthy cells → blebbing = irregular bulbe
- Necrosis – cell swelling, leakage of contents
- Apoptosis – cell shrinkage, apoptotic bodies

Biological contaminations
- Bacteria, yeast, molds, viruses, mycoplasm
Growth curve cells
- Lag phase, log phase, stationary phase, death phase

Culture environment
- Temperature (RT)
- CO2 concentration (5%)
- Humidity in air
- pH (7.4), phenal red indicator
o Acid: orange → yellow
o Base: orange → pink/purple
- Osmotic pressure
- Concentration nutrients, proteins, hormones

Basal media
- DMEM → high glucose
- IMDM → HEPES buffered
- Additions
o FBS (fetal bovine serum), source of growth and adhesion factors, hormones, lipids, minerals
o AA, anti biotic anti miotic
o Glutamine, essential amino acid

GMSO classification
- ML-I → ML-IV (minimum containment levels)

Cell counting → 16 squares, 50-150 cells

Cancer cells = undifferentiated, characteristics of stem cells, not perform normal function
- The less differentiated the more malignant the cancer
- Neoplasm = new growth

Inherited mutations → cell cycle, DNA repair, apoptosis
- Fail DNA repair → activation oncogenes, inactivation genes apoptosis, inactivation TSG
Somatic mutations → riskfactors
- Environmental mutagens
- Hormones
- Immunosuppression
- Oncogenic virus infections

, DNA viruses
- Papillomavirus, carcinoma of uterine cervix
- Hepatitis B virus, liver cancer
- Epstein-Bar virus, Burkitt’s lymphoma
RNA viruses
- HIV-1, immunodeficiency
- HHV-8, herpes
- Kaposi’s sarcoma

Proto-oncogenes = code for proteins in cell division (growth factors, membrane receptors, signaling
ras gene)
- Oncogenes = abnormally active protein = gain of function (missense mutation)
- Wnt signaling pathway, gene transcription
Tumor suppressor genes = code for proteins that prevent uncontrolled cell division by blocking key
steps (p53 gene, prevent cell entering S phase, repair DNA, cause apoptosis)
- Loss of function (nonsense/frameshift)

Knudson’s two-hit hypothesis
- Need 2 hits, or germ cell mutation and 1 hit

Cell cycle
- G0 → G1 → S (inhibited by p53, Rb) → G2 → M (mitosis)
- Inhibition removed by cyclin-dependent kinases (CDK)

Tumor immune evasion = inactivation T cells with CTLA-4 and PD1
- Downregulation MHC class I, TGF-β and IL-10
- Downregulation co-stimulatory molecules
- Loss tumor antigens
- Production suppressive cytokines
- Upregulation inhibitory receptors (PD-L1/2), blocks T cell function

Written for

Institution
Study
Course

Document information

Uploaded on
April 7, 2025
Number of pages
19
Written in
2023/2024
Type
Class notes
Professor(s)
Prof. dr. annemiek van spriel en jeanette pots
Contains
All classes

Subjects

$7.44
Get access to the full document:

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Get to know the seller
Seller avatar
hulshofcato2
3.0
(2)

Get to know the seller

Seller avatar
hulshofcato2 Radboud Universiteit Nijmegen
Follow You need to be logged in order to follow users or courses
Sold
8
Member since
1 year
Number of followers
0
Documents
19
Last sold
3 months ago

3.0

2 reviews

5
1
4
0
3
0
2
0
1
1

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions